De-adoption of chlorhexidine oral care and ICU mortality. Authors' reply

Craig Dale^{1

2

3

4

5}, Brian Cuthbertson^{6

7

8

9}

Affiliations

¹ Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, #130-155 College Street, Toronto, ON, M5T1P8, Canada. craig.dale@utoronto.ca.
² Tory Trauma Program, Sunnybrook Health Sciences Centre, Toronto, Canada. craig.dale@utoronto.ca.
³ University of Toronto Centre for the Study of Pain, Toronto, Canada. craig.dale@utoronto.ca.
⁴ Sunnybrook Research Institute, Toronto, Canada. craig.dale@utoronto.ca.
⁵ Interdepartmental Division of Critical Care, Department of Medicine, Surgery, Anaesthesia and Paediatrics, Li Ka Shing Knowledge Institute, 204 Victoria Street, 4th Floor, Room 411, Toronto, ON, M5B 1T8, Canada. craig.dale@utoronto.ca.
⁶ Sunnybrook Research Institute, Toronto, Canada.
⁷ Interdepartmental Division of Critical Care, Department of Medicine, Surgery, Anaesthesia and Paediatrics, Li Ka Shing Knowledge Institute, 204 Victoria Street, 4th Floor, Room 411, Toronto, ON, M5B 1T8, Canada.
⁸ Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, D108 - 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada.
⁹ Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Canada.

Comment

Craig Dale et al. Intensive Care Med. 2022 May.

. 2022 May;48(5):626-627.

doi: 10.1007/s00134-022-06649-6. Epub 2022 Feb 16.

Craig Dale^{1

2

3

4

5}, Brian Cuthbertson^{6

7

8

9}

¹ Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, #130-155 College Street, Toronto, ON, M5T1P8, Canada. craig.dale@utoronto.ca.
² Tory Trauma Program, Sunnybrook Health Sciences Centre, Toronto, Canada. craig.dale@utoronto.ca.
³ University of Toronto Centre for the Study of Pain, Toronto, Canada. craig.dale@utoronto.ca.
⁴ Sunnybrook Research Institute, Toronto, Canada. craig.dale@utoronto.ca.
⁵ Interdepartmental Division of Critical Care, Department of Medicine, Surgery, Anaesthesia and Paediatrics, Li Ka Shing Knowledge Institute, 204 Victoria Street, 4th Floor, Room 411, Toronto, ON, M5B 1T8, Canada. craig.dale@utoronto.ca.
⁶ Sunnybrook Research Institute, Toronto, Canada.
⁷ Interdepartmental Division of Critical Care, Department of Medicine, Surgery, Anaesthesia and Paediatrics, Li Ka Shing Knowledge Institute, 204 Victoria Street, 4th Floor, Room 411, Toronto, ON, M5B 1T8, Canada.
⁸ Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, D108 - 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada.
⁹ Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Canada.

No abstract available

Comment on

Effect of oral chlorhexidine de-adoption and implementation of an oral care bundle on mortality for mechanically ventilated patients in the intensive care unit (CHORAL): a multi-center stepped wedge cluster-randomized controlled trial.
Dale CM, Rose L, Carbone S, Pinto R, Smith OM, Burry L, Fan E, Amaral ACK, McCredie VA, Scales DC, Cuthbertson BH. Dale CM, et al. Intensive Care Med. 2021 Nov;47(11):1295-1302. doi: 10.1007/s00134-021-06475-2. Epub 2021 Oct 5. Intensive Care Med. 2021. PMID: 34609548 Free PMC article. Clinical Trial.
De-adoption of chlorhexidine oral care and ICU mortality.
Blot S, Deschepper M, Labeau S. Blot S, et al. Intensive Care Med. 2022 May;48(5):624-625. doi: 10.1007/s00134-022-06621-4. Epub 2022 Jan 17. Intensive Care Med. 2022. PMID: 35037992 No abstract available.